Singapore, March 4 -- Offering scalable quality grades from Research to GMP, PlasmidFactory supports advanced gene-based innovations worldwide.

Minicircle DNA - The Core Technology for Next-Generation Therapies

PlasmidFactory's patented Minicircle DNA technology removes all bacterial backbone sequences, leaving only the therapeutic expression cassette in a small, supercoiled DNA molecule.

This minimalistic vector design enables:

-Reduced immunogenicity and lower DNA toxicity-Higher transfection efficiency and improved cell viability-Stronger, more stable gene expression-Backbone-free design available up to GMP Grade for safer, regulatory-aligned manufacturing

Minicircle DNA provides clear advantages across advanced applications. It e...